Patients with atrial flutter who are undergoing cardioversion should receive full anticoagulation before, during and after the procedure

Author：  

Publisher： Adis International

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1227, 2000-01, pp. : 4-4

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Anticoagulation during Cardioversion in Patients with Atrial Fibrillation: Current Clinical Practice

By Stellbrink Christoph   Schimpf Thomas  

American Journal of Cardiovascular Drugs, Vol. 5, Iss. 3, 2005-01 ,pp. : 155-162

Adis International

Access to resources Recommend Favorite

The Use of Drugs for Cardioversion of Recent Onset Atrial Fibrillation and Flutter: Focus on Ibutilide

By Obel O.A.   Camm A.J.  

Drugs & Aging, Vol. 12, Iss. 6, 1998-06 ,pp. : 461-476

Adis International

Access to resources Recommend Favorite

Who should receive early ACE inhibitor therapy after MI?

By  

Inpharma, Vol. 1, Iss. 1272, 2001-01 ,pp. : 16-17

Adis International

Access to resources Recommend Favorite

Economic Evaluation of Enoxaparin for Anticoagulation in Early Cardioversion of Persisting Nonvalvular Atrial Fibrillation: A Statutory Health Insurance Perspective from Germany

By Schädlich Peter K.  

American Journal of Cardiovascular Drugs, Vol. 7, Iss. 3, 2007-01 ,pp. : 199-217

Adis International

Access to resources Recommend Favorite

Effectiveness of a computerized decision support system for anticoagulation management in hemodialysis patients: A before–after study

By  

Hemodialysis International, Vol. 20, Iss. 4, 2016-10 ,pp. : 530-536

John Wiley & Sons Inc

Access to resources Recommend Favorite